Publications

 

In the publications section you can find the Company’s Annual Reports, Quarterly Reports/Statements, our Sustainability Report 2020 as well as non-financial statements from 2017-2019. Furthermore, there are available presentations held at Investor Relations events and analyst calls. 

 

Financial Reports and Sustainability Reports

Please find below Evotec's financial reports from 1999 onwards as well as respective corresponding documents such as corporate news and analyst presentations.

An overview of all published sustainability-related reports can also be found in the ESG Performance section under this link.

 

Financial Reports Archive

2020

Annual Report

Sustainability Report

Financial Statements

Bericht zum ersten Halbjahr

2019

Financial Statements

Separate non-financial group report

Webcast/Conference call regarding the acquisition of Just.Bio

2018

Annual Report

Financial Statements

Separate non-financial group report

Webcast/Conference call regarding the fiscal year 2018 results

2017

Annual Report

Financial Statements

Separate non-financial group report

Webcast/Conference call regarding the fiscal year 2017 results

Conference Call/Webcast regarding the acquisition of Aptuit

2016

Financial Statements

Conference Call/Webcast regarding strategic collaboration with Celgene

Conference Call/Webcast regarding the offer to acquire Cyprotex

2014

Financial Statements

Conference Call/Webcast announcing negotiations on major collaboration with Sanofi

2011

Annual Report

Financial Statements

Conference call Webcast announcing licence argeement with Roche

Conference call and Webcast announcing the acquisition of Compound Focus, Inc.

Conference call and Webcast announcing the acquisition of Kinaxo

2010

Financial Statements

Conference call and Webcast announcing the alliance with MedImmune

Third Quarter Report

Half Year Report

Conference call and Webcast announcing the acquisition of DeveloGen

First Quarter Report

2009

Financial Statements

Third Quarter Report

Half Year Report

First Quarter Report

2008

Financial Statements

Third Quarter Report

Half Year Report

First Quarter Report

2007

Annual Report

Financial Statements

Third Quarter Report

Half Year Report

First Quarter Report

2006

Annual Report

Financial Statements According to HGB

Third Quarter Report

Second Quarter Report

First Quarter Report

2005

Annual Report

Third Quarter Report

Second Quarter Report

First Quarter Report

New Segmental P&L Statements

2004

Third Quarter Report

Second Quarter Report

First Quarter Report

2003

Annual Report

Third Quarter Report

Second Quarter Report

First Quarter Report

2002

Annual Report

Third Quarter Report

Second Quarter Report

First Quarter Report

2001

Annual Report

Third Quarter Report

Second Quarter Report

First Quarter Report

2000

Annual Report

Third Quarter Report

Second Quarter Report

First Quarter Report

Oxford Asymmetry International plc 2000 Interim Statement

Oxford Asymmetry International plc 2000 Interim Statement

1999

Annual Report

Third Quarter Report

Oxford Asymmetry International plc Annual Report 1999

SEC Filings

On this page you can find all documents published in realation to our public listing on NASDAQ. 

For the original documents published on the EDGAR ("Electronic Data Gathering, Analysis, and Retrieval") database of the U.S. Securities and exchange commission ("SEC"), please use the below link.

Link to SEC EDGAR platform


Three shareholders, Novo Holdings A/S, T. Rowe Price Group Inc. and Mubadala Investment Company, currently hold more than 5% of the shares of Evotec SE. The free float according to the definition of the Frankfurt Stock Exchange is approx. 68% according to our estimates (Evotec: 11|2021).

Presentations

Below you will find the current Evotec corporate presentation as well as various presentations given at Evotec events such as the Capital Markets Day, our quarterly analyst meetings and international investor conferences.

IR Presentations

TOP